Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) 2.0 - operational costs for capacity building
InnoVet-AMR 2.0 is a continuation of InnoVet-AMR 1.0, a CAD30.4-million partnership between IDRC and the United Kingdom Department for Health and Social Care’s Global Antimicrobial Resistance Innovation Fund. It is aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security. Inno-Vet-AMR has supported 11 projects that seek developing alternatives to antimicrobials in swine, poultry and aquaculture.
InnoVet-AMR 2.0 will support selected projects from InnoVet-AMR 1.0 based on achievements to help advance the candidate products through the product development pipeline towards commercialization. InnoVet-AMR 2.0 will also support new projects, which will include farm ruminants and aquaculture species, to increase the animal health portfolio in the search for new solutions to mitigate AMR.
This project will support the Fund for InnoVet-AMR 2.0 by covering the operational costs, including salaries and benefits, office costs and travel of IDRC staff. Separate project approval documents will authorize the execution of individual research projects and activities related to program governance, communication and evaluation.